Shaun R. Coughlin, MD, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Shaun R. Coughlin, MD, PhD

Director, Cardiovascular Research Institute, UCSF
Distinguished Professorship in Cardiovascular Biology and Medicine, UCSF

shaun.coughlin@ucsf.edu

Phone: (415) 502-8667
Box 3122, UCSF
San Francisco, CA 94158-3122

View on UCSF Profiles

Cancer Center Membership

Associate Member » Hematopoietic Malignancies

Education

Massachusetts Institute of Technology, Boston, MA, S.B., S.B., 1976, Biology, Physics
Massachusetts Institute of Technology, Boston, MA, S.M., 1976, Biochemistry
Massachusetts Institute of Technology, Boston, MA, Ph.D., 1981, Neur. and Endo. Reg.
Harvard Medical School, Boston, MA, M.D., 1982, Medicine


Professional Experience

  • 1982-1984
    Intern and Resident, Medical Services, Massachusetts General Hospital
  • 1984-1985
    Assistant Research Cardiologist, Cardiovascular Research Inst., UCSF
  • 1985-1986
    Clinical Fellow in Cardiology, University of California, San Francisco
  • 1986-1991
    Assistant Professor of Medicine and Associate Staff, Cardiovascular Research Intitute, UCSF
  • 1991-1996
    Associate Professor of Medicine and Senior Staff, Cardiovascular Research Institute, UCSF
  • 1992-present
    Member, Graduate Program in Biological Sciences and Program in Biomedical Sciences, UCSF
  • 1995-present
    Director, Daiichi Research Center, UCSF
  • 1996-present
    Professor of Medicine, UCSF
  • 1997-present
    Professor of Cellular and Molecular Pharmacology, UCSF
  • 1997-present
    Director, Cardiovascular Research Institute, UCSF

Honors & Awards

  • Established Investigator, AHA; Ted Zimmerman Lecture, ASH, 1991
  • 1992
    ASCI
  • 1994
    Syntex Prize in Receptor Pharmacology
  • 1997
    AAP; Owren Lecture, Oslo; AHA Sol Sherry Lecture
  • 1998
    Outstanding Investigator Award, AFMR
  • 2000
    Hoeg Award, AHA
  • 2000
    Fellow, American Academy of Arts and Sciences
  • 2000
    Russel Ross Lecture, AHA
  • 2002
    Pasarow Foundation Award for Cardiovascular Research
  • 2003
    Basic Science Prize, AHA
  • 2004
    14th Bristol-Meyers Squibb Award for Distinguished Achievement in Cardiovascular Research
  • 2004
    Member, National Academy of Sciences

Selected Publications

  1. Identifying and quantifying two ligand-binding sites while imaging native human membrane receptors by AFM. Nat Commun. 2015; 6:8857.
    View on PubMed
  2. An internal promoter underlies the difference in disease severity between N- and C-terminal truncation mutations of Titin in zebrafish. Elife. 2015; 4.
    View on PubMed
  3. Non-invasive imaging and cellular tracking of pulmonary emboli by near-infrared fluorescence and positron-emission tomography. Nat Commun. 2015; 6:8448.
    View on PubMed
  4. Mice expressing a mutant form of fibrinogen that cannot support fibrin formation exhibit compromised antimicrobial host defense. Blood. 2015 Oct 22; 126(17):2047-58.
    View on PubMed
  5. Imaging G protein-coupled receptors while quantifying their ligand-binding free-energy landscape. Nat Methods. 2015 Sep; 12(9):845-51.
    View on PubMed
  6. Analysis of Cardiomyocyte Development using Immunofluorescence in Embryonic Mouse Heart. J Vis Exp. 2015; (97).
    View on PubMed
  7. Gai/o-coupled receptor signaling restricts pancreatic ß-cell expansion. Proc Natl Acad Sci U S A. 2015 Mar 3; 112(9):2888-93.
    View on PubMed
  8. Mechanical vessel injury in zebrafish embryos. J Vis Exp. 2015; (96).
    View on PubMed
  9. Improved Upper Limits on the Stochastic Gravitational-Wave Background from 2009-2010 LIGO and Virgo Data. Phys Rev Lett. 2014 Dec 5; 113(23):231101.
    View on PubMed
  10. Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race. Blood. 2014 Nov 27; 124(23):3450-8.
    View on PubMed
  11. Redundancy and interaction of thrombin- and collagen-mediated platelet activation in tail bleeding and carotid thrombosis in mice. Arterioscler Thromb Vasc Biol. 2014 Dec; 34(12):2563-9.
    View on PubMed
  12. The imperative to invest in science has never been greater. J Clin Invest. 2014 Sep 2; 124(9):3680-1.
    View on PubMed
  13. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature. 2013 Oct 3; 502(7469):105-9.
    View on PubMed
  14. IL-7 production in murine lymphatic endothelial cells and induction in the setting of peripheral lymphopenia. Int Immunol. 2013 Aug; 25(8):471-83.
    View on PubMed
  15. High-resolution crystal structure of human protease-activated receptor 1. Nature. 2012 Dec 20; 492(7429):387-92.
    View on PubMed
  16. PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest. 2013 Jan 2; 123(1):206-14.
    View on PubMed
  17. TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation. Cell. 2012 Sep 28; 151(1):111-22.
    View on PubMed
  18. Wnt/ß-catenin signaling is differentially regulated by Ga proteins and contributes to fibrous dysplasia. Proc Natl Acad Sci U S A. 2011 Dec 13; 108(50):20101-6.
    View on PubMed
  19. GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood. Science. 2011 Sep 30; 333(6051):1898-903.
    View on PubMed
  20. Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome. Blood. 2011 Oct 13; 118(15):4015-23.
    View on PubMed

Go to UCSF Profiles, powered by CTSI